NCT06179953 Emotional Skills Training with Social Robot
| NCT ID | NCT06179953 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto per la Ricerca e l'Innovazione Biomedica |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-06-05 |
| Primary Completion | 2024-02-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2023-06-05 with a primary completion date of 2024-02-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism is a neurodevelopmental disorder that involves difficulties especially in the sphere of social interaction, social communication, and restricted and stereotyped behavior patterns. In particular, emotional regulation is a central developmental skill. In fact, the emotional dysregulation observed in children with autism results in increased social and behavioral difficulties over time. Therefore, the present protocol aims to test the role of a human-assisted social robot as a mediator of social-emotional understanding intervention for children with autism spectrum disorders (ASD). The children, will be divided into two groups, an experimental one in which training will be conducted through the use of social robot and control group which will be conducted through traditional therapy.
Eligibility Criteria
Inclusion Criteria: * Language in sentences * use of connectors * ability to narrate events not present * ADOS level: module 2 * Griffiths: QS\>75 Exclusion Criteria: * presence of other medical disorders
Contact & Investigator
Flavia Marino
PRINCIPAL INVESTIGATOR
Istituto per la Ricerca e l'Innovazione Biomedica
Frequently Asked Questions
Who can join the NCT06179953 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 10 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06179953 currently recruiting?
Yes, NCT06179953 is actively recruiting participants. Contact the research team at germana.doria@irib.cnr.it for enrollment information.
Where is the NCT06179953 trial being conducted?
This trial is being conducted at Messina, Italy.
Who is sponsoring the NCT06179953 clinical trial?
NCT06179953 is sponsored by Istituto per la Ricerca e l'Innovazione Biomedica. The principal investigator is Flavia Marino at Istituto per la Ricerca e l'Innovazione Biomedica. The trial plans to enroll 20 participants.